Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_assertion type Assertion NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_head.
- NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_provenance.
- NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_assertion evidence source_evidence_literature NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_provenance.
- NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_assertion SIO_000772 12514133 NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_provenance.
- NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_assertion wasDerivedFrom befree-20140225 NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_provenance.
- NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_assertion wasGeneratedBy ECO_0000203 NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_provenance.